Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Embla Medical hf's share price for the quarter that ended in Mar. 2026 was kr26.5. Embla Medical hf's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 427 Mil. Therefore, Embla Medical hf's market cap for the quarter that ended in Mar. 2026 was kr11,321 Mil.
Embla Medical hf's quarterly market cap
increased
from Sep. 2025 (kr13,320 Mil) to Dec. 2025 (kr13,902 Mil) but then
declined
from Dec. 2025 (kr13,902 Mil) to Mar. 2026 (kr11,321 Mil).
Embla Medical hf's annual market cap
increased
from Dec. 2023 (kr11,537 Mil) to Dec. 2024 (kr15,199 Mil) but then
declined
from Dec. 2024 (kr15,199 Mil) to Dec. 2025 (kr13,902 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Embla Medical hf's Enterprise Value for Today is kr14,549 Mil.
Embla Medical hf (OCSE:EMBLA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Embla Medical hf Market Cap Related Terms
Embla Medical hf Market Cap Historical Data
* Premium members only.
The historical data trend for Embla Medical hf's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OCSE:EMBLA vs ABT, SYK, MDT: Market Cap Comparison
For the Medical Devices subindustry, Embla Medical hf's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embla Medical hf Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Market Cap distribution charts can be found below:
* The bar in red indicates where Embla Medical hf's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Embla Medical hf's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Embla Medical hf (OCSE:EMBLA) has a Market Cap of kr11,498 Mil as of Jul. 07, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Embla Medical hf and its competitors. According to the industry distribution chart, Embla Medical hf ranks #119 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 13.7%.
Is Embla Medical hf's Market Cap too high?
Embla Medical hf's current Market Cap is kr11,498 Mil. Based on the distribution chart, Embla Medical hf ranks #119 out of 868 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Embla Medical hf has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Embla Medical hf ranks #119 out of 868 companies for Market Cap. This places Embla Medical hf in the top 14% of its industry — outperforming the majority of peers. The industry median Market Cap is 121.35. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 121.35, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Embla Medical hf and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 121.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Embla Medical hf's current Market Cap is kr11,498 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Based on GuruFocus' analysis, Embla Medical hf (OCSE:EMBLA) is currently considered Modestly Undervalued. The stock's GF Value™ is kr34.58, compared to a current price of kr27.00 — trading 21.9% below its estimated fair value. The current Market Cap is kr11,498 Mil. Embla Medical hf's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Embla Medical hf (OCSE:EMBLA), the current Market Cap is kr11,498 Mil as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Embla Medical hf (OCSE:EMBLA) Overvalued in 2026?
Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued.
The current stock price of kr27.00 is trading 21.9% below its estimated GF Value™ of kr34.58.
GuruFocus considers Embla Medical hf to be Modestly Undervalued.
Key valuation signals for OCSE:EMBLA:
Market Cap: kr11,498 Mil
GF Value™: kr34.58 vs. price of kr27.00 (21.9% below fair value)
No single metric tells the full story. See the OCSE:EMBLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
92GF Score
Get the complete analysis for OCSE:EMBLA
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OCSE:EMBLA has been successfully added to your 
